Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_provenance.
- NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_assertion description "[The PI3K/mammalian Target of Rapamycin (mTOR) pathway is often aberrantly activated in rhabdomyosarcoma (RMS) and represents a promising therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_provenance.
- NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_assertion evidence source_evidence_literature NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_provenance.
- NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_assertion SIO_000772 24133218 NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_provenance.
- NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_assertion wasDerivedFrom befree-2016 NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_provenance.
- NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_assertion wasGeneratedBy ECO_0000203 NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1120107.RAtN3bR4N0GntublNk9_BlKv9onynqHWwIXK04cDIuaLE130_provenance.